United States - English - NLM (National Library of Medicine)

bryant ranch prepack - isoniazid (unii: v83o1voz8l) (isoniazid - unii:v83o1voz8l) - isoniazid 100 mg - isoniazid tablets are recommended for all forms of tuberculosis in which organisms are susceptible. however, active tuberculosis must be treated with multiple concomitant anti-tuberculosis medications to prevent the emergence of drug resistance. single-drug treatment of active tuberculosis with isoniazid or any other medication, is inadequate therapy. isoniazid tablets are recommended as preventive therapy for the following groups, regardless of age. (note: the criterion for a positive reaction to a skin test (in millimeters of induration) for each group is given in parenthesis): - persons with human immunodeficiency virus (hiv) infection (greater than or equal to 5 mm) and persons with risk factors for hiv infection whose hiv infection status is unknown but who are suspected of having hiv infection. preventive therapy may be considered for hiv infected persons who are tuberculin-negative but belong to groups in which the prevalence of tuberculosis infection is high. candidates for preventive therapy who have

United States - English - NLM (National Library of Medicine)

northwind pharmaceuticals, llc - isoniazid (unii: v83o1voz8l) (isoniazid - unii:v83o1voz8l) - isoniazid 300 mg - isoniazid is recommended for all forms of tuberculos in which organisms are susceptible. however, active tuberculosis must be treated with multiple concomitant antituberculosis medications to prevent the emergence of drug resistance. single-drug treatment of active tuberculos with isoniazid, or any other medication, is inadequate therapy. isoniazid is recommended as preventive therapy for the following groups, regardless of age. (note: the criterion for a positive reaction to a skin test (in millimeters of induration) for each group is given in parenthesis): 1. persons with human immunodeficiency virus (hiv) infection (≥ 5 mm) and persons with risk factors for hiv infection whose hiv infection status is unknown but who are suspected of having hiv infection. preventive therapy may be considered for hiv infected persons who are tuberculin- negative but belong to groups in which the prevalence of tuberculosis infection is high. candidates for preventive therapy who have hiv infection should have a minimum of 12

United States - English - NLM (National Library of Medicine)

a-s medication solutions - isoniazid (unii: v83o1voz8l) (isoniazid - unii:v83o1voz8l) - isoniazid 300 mg - isoniazid tablets, usp are recommended for all forms of tuberculosis in which organisms are susceptible. however, active tuberculosis must be treated with multiple concomitant anti-tuberculosis medications to prevent the emergence of drug resistance. single-drug treatment of active tuberculosis with isoniazid or any other medication, is inadequate therapy. isoniazid tablets, usp are recommended as preventive therapy for the following groups, regardless of age. (note: the criterion for a positive reaction to a skin test (in millimeters of induration) for each group is given in parenthesis): - persons with human immunodeficiency virus (hiv) infection (greater than or equal to 5 mm) and persons with risk factors for hiv infection whose hiv infection status is unknown but who are suspected of having hiv infection. preventive therapy may be considered for hiv infected persons who are tuberculin-negative but belong to groups in which the prevalence of tuberculosis infection is high. candidates for preventive therap

United States - English - NLM (National Library of Medicine)

a-s medication solutions - isoniazid (unii: v83o1voz8l) (isoniazid - unii:v83o1voz8l) - isoniazid 50 mg in 5 ml - isoniazid oral solution is recommended for all forms of tuberculosis in which organisms are susceptible. however, active tuberculosis must be treated with multiple concomitant anti-tuberculosis medications to prevent the emergence of drug resistance. single-drug treatment of active tuberculosis with isoniazid or any other medication is inadequate therapy. isoniazid oral solution is recommended as preventive therapy for the following groups, regardless of age. (note: the criterion for a positive reaction to a skin test (in millimeters of induration) for each group is given in parenthesis): - persons with human immunodeficiency virus (hiv) infection (greater than or equal to 5 mm) and persons with risk factors for hiv infection whose hiv infection status is unknown but who are suspected of having hiv infection. preventive therapy may be considered for hiv infected persons who are tuberculin-negative but belong to groups in which the prevalence of tuberculosis infection is high. candidates for preventive therapy

Kenya - English - Pharmacy and Poisons Board

isoniazid bp - dispersible tablet - isoniazid bp 100mg - isoniazid

Kenya - English - Pharmacy and Poisons Board

isoniazid - tablet - isoniazid 300mg - isoniazid

Malta - English - Medicines Authority

morningside healthcare limited unit c, harcourt way, leicester, le19 1wp, united kingdom - isoniazid - tablet - isoniazid 100 mg - antimycobacterials

New Zealand - English - Medsafe (Medicines Safety Authority)

noumed pharmaceuticals limited - isoniazid 100mg - tablet - 100 mg - active: isoniazid 100mg excipient: lactose monohydrate magnesium stearate purified water wheat starch as 9.50mg + 60.9mg (includes 10% overage for loss on drying) - isoniazid is indicated for the treatment of pulmonary and extrapulmonary tuberculosis in combination with other antitubercular agents.

Canada - English - Health Canada

pendopharm division of pharmascience inc - isoniazid - tablet - 100mg - isoniazid 100mg - antituberculosis agents

Canada - English - Health Canada

pendopharm division of pharmascience inc - isoniazid - tablet - 300mg - isoniazid 300mg - antituberculosis agents